Abstract: A device for supporting a laboratory object is provided. The device may comprise a body extending about and defining an opening. The body may be positioned in a customized orientation selected from a plurality of orientations. The device may include a first support defined by the body and configured to contact a surface when the body is in a first orientation. The device may include a second support coupled to the first support. The second support may be configured to contact the surface when the body is in a second orientation.

Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.

Abstract: In one embodiment according to the present invention, a stent is described having a generally cylindrical body formed from a single woven nitinol wire. The distal and proximal ends of the stent include a plurality of loops, some of which include marker members used for visualizing the position of the stent. In another embodiment, the previously described stent includes an inner flow diverting layer.

Abstract: Systems and methods are disclosed for compiling, curating, and sharing digital content. A content clearinghouse server can compile digital content items received from a number of content sources and curate the digital content items for a user of a client device. The content clearinghouse server can also receive information from client devices to be broadcast to a number of different platforms. Digital content items received from content sources and broadcast information can each be de-duplicated at the content clearinghouse server.

Abstract: The present disclosure provides methods for isolating proteins and optionally nucleic acids from a sample, comprising: (a) contacting a sample, a lysate of the sample, a supernatant of the lysate, or a portion of the sample, the lysate or the supernatant with one or more first agents selected from low molecular weight carboxylates and sulfate and one or more second agents that are multivalent (e.g., trivalent) salt(s) to generate a mixture, (b) separating the mixture of step (a) into a solid phase and a liquid phase, wherein the one or more second agents are primarily in the solid phase, and (c) isolating proteins and optionally nucleic acids from the liquid phase of step (b). Compositions and kits useful in such methods are also disclosed.

Abstract: Diesel boiling-range fuel blends including renewable diesel, biodiesel, and petrodiesel, where the diesel boiling-range fuel blend is capable of producing a minimal volume change of at least one swellable elastomer in a diesel boiling-range fuel system are provided herein. Methods of making the diesel boiling-range fuel blend as well as methods of reducing swellable elastomer shrinkage are also provided herein.

Abstract: Embodiments are generally directed to techniques for extracting contextually structured data from document images, such as by automatically identifying document layout, document data, and/or document metadata in a document image, for instance. Many embodiments are particularly directed to generating and utilizing a document template database for automatically extracting document image contents into a contextually structured format. For example, the document template database may include a plurality of templates for identifying/explaining key data elements in various document image formats that can be used to extract contextually structured data from incoming document images with a matching document image format. Several embodiments are particularly directed to automatically identifying and associating document metadata with corresponding document data in a document image, such as for generating a machine-facilitated annotation of the document image.

Abstract: Techniques for creating and managing wagers on possible states within a live event, such as possible outcomes of subparts of a sporting event or other possible occurrences within the event. An initial state and multiple possible future states of a performance parameter of the event are determined based on state information of the event. A betting market may be created by determining probabilities and odds for the possible future states. Bets may be made on the possible future states via a touch-sensitive display. A payout may be made to a winner who selects a possible future state that actually occurs.

Abstract: The invention generally relates to methods of treating viral infections using known drugs and pharmaceutical compositions comprising same. More specifically, the disclosed methods are useful for the treatment of viral infections that are enveloped viruses. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The invention provides compositions and methods for treating diseases associated with expression of BCMA. The invention also relates to chimeric antigen receptor (CAR) specific to BCMA vectors encoding the same, and recombinant T cells comprising the BCMA CAR. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises a BCMA binding domain.

Abstract: Described herein are methods, compositions and kits directed to amplification of nucleic acids suitable for both next generation sequencing (NGS) and a second round of sequencing as validation, such as Sanger sequencing.

Abstract: A tinted glass composition and glass article including the same, the composition including: about 45 mol % to about 80 mol % SiO2; about 6 mol % to about 22 mol % Al2O3; 0 mol % to about 25 mol % B2O3; about 7 mol % to about 25 mol % of at least one alkaline earth oxide selected from MgO, CaO, SrO, BaO, and combinations thereof; about 0.5 mol % to about 20 mol % CuO; 0 mol % to about 6 mol % SnO2, SnO, or a combination thereof; 0 mol % to about 1.0 mol % C; 0 mol % to about 5 mol % La2O3; and 0 mol % to about 10 mol % PbO, and that is substantially free of alkali metal.

Abstract: An acid gas absorber includes a co-current flue gas-lean solution section and a packed counter-current flue gas-liquid phase section useful in a method of capturing an acid gas from flue gas in a more efficient and cost effective manner.

Abstract: The present invention relates to compounds of Formula (XI): wherein R1a, R2a, R3a, R4a, R5a, R6a, and Aa are as defined herein, and pharmaceutically acceptable salts thereof. The compounds of the present invention are inhibitors of hematopoietic prostaglandin D synthase (H-PGDS) inhibitors and can be useful in the treatment of Duchenne Muscular Dystrophy. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting H-PGDS activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

Abstract: A composition and method for the photometric determination of a film-forming amine in liquid by adding an indicator reagent to an aqueous system that is pH dependent, combining a water soluble non-ionic polymer to modify the physical properties of the aqueous system, and adding an acidic buffer to said aqueous system to lower pH and activate said indicator, said water soluble polymer keeping the filming amine/indicator complex in solution despite the acidic buffer and preventing it from precipitating out.

Abstract: Embodiments of methods and apparatuses for forming the metal oxide nanostructure on surfaces are disclosed. In certain embodiments, the nanostructures can be formed on a substrate made of a nickel titanium alloy, resulting in a nanostructure that can include both titanium oxide and nickel oxide. The nanostructure can be formed on the surface(s) of an implantable medical device, such as a stent.